These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7698189

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 5-HT autoreceptors in the regulation of 5-HT release from guinea pig raphe nucleus and hypothalamus.
    Moret C, Briley M.
    Neuropharmacology; 1997; 36(11-12):1713-23. PubMed ID: 9517443
    [Abstract] [Full Text] [Related]

  • 23. Effects of 5-HT and 5-HT1A receptor agonists and antagonists on dorsal vagal preganglionic neurones in anaesthetized rats: an ionophoretic study.
    Wang Y, Jones JF, Ramage AG, Jordan D.
    Br J Pharmacol; 1995 Oct; 116(4):2291-7. PubMed ID: 8564262
    [Abstract] [Full Text] [Related]

  • 24. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist.
    Fletcher A, Forster EA, Bill DJ, Brown G, Cliffe IA, Hartley JE, Jones DE, McLenachan A, Stanhope KJ, Critchley DJ, Childs KJ, Middlefell VC, Lanfumey L, Corradetti R, Laporte AM, Gozlan H, Hamon M, Dourish CT.
    Behav Brain Res; 1996 Oct; 73(1-2):337-53. PubMed ID: 8788530
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J, Schohe-Loop R, Heine HG, Greuel JM, Mauler F, Schmidt B, Sommermeyer H, Glaser T.
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The role of 5-HT1D and 5-HT1A receptors in mediating 5-hydroxytryptophan induced myoclonic jerks in guinea pigs.
    Hagan JJ, Hatcher JP, Slade PD.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):743-51. PubMed ID: 8750741
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
    Corradetti R, Le Poul E, Laaris N, Hamon M, Lanfumey L.
    J Pharmacol Exp Ther; 1996 Aug 29; 278(2):679-88. PubMed ID: 8768719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus.
    Mundey MK, Fletcher A, Marsden CA.
    Neuropharmacology; 1994 Jan 29; 33(1):61-6. PubMed ID: 8183439
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar 29; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Further assessment of the antagonist properties of the novel and selective 5-HT1A receptor ligands (+)-WAY 100 135 and SDZ 216-525.
    Lanfumey L, Haj-Dahmane S, Hamon M.
    Eur J Pharmacol; 1993 Nov 02; 249(1):25-35. PubMed ID: 8282017
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.